Suppressive activity of vitamin D3 on matrix metalloproteinase production from cholesteatoma keratinocytes in vitro

Mediators of Inflammation

Volumn 2005, Issue 4, 2005, Pages 210-215

  Kobayashi, Hitome ^a   Asano, Kazuhito ^a   Kanai, Ken Ichi ^a   Suzaki, Harumi ^a  

^a SHOWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COLECALCIFEROL;

ARTICLE; CANCER PREVENTION; CELL STIMULATION; CHOLESTEATOMA; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; ENZYME ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME REPRESSION; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; KERATINOCYTE; PRIORITY JOURNAL; SUPERNATANT; TUMOR CELL; TUMOR CELL CULTURE;

CELLS, CULTURED; CHOLECALCIFEROL; CHOLESTEATOMA; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; KERATINOCYTES; MALE; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 3; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; VITAMINS;

EID: 25644434168     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/MI.2005.210     Document Type: Article

References (20)

1. Shibosawa E, Tsutsumi K, Takakuwa T, Takahashi T. Stromal expression of matrix metalloprotease-9 in middle ear cholesteatomas. Am J Otology. 2000;21(5):621-624.
2. Madri JA, Basson MD. Extracellular matrix-cell interactions: dynamic modulators of cell, tissue and organism structure and function. Lab Invest. 1992;66(5):519-521.
3. Schmidt M, Grunsfelder P, Hoppe F. Up-regulation of matrix metalloprotease-9 in middle ear cholesteatoma-correlations with growth factor expression in vivo? Eur Arch Otorhinolaryngol. 2001;258(9):472-476.
4. Banerjee AR, James R, Narula AA, Lee RJ. Matrix metalloproteinase-1 in cholesteatoma, middle ear granulations and deep meatal skin: a comparative analysis. Clin Otolaryngol. 1998;23(6):515-519.
5. Schultz GS, Strelow S, Stern GA, et al. Treatment of alkali-injured rabbit corneas with a synthetic inhibitor of matrix metalloproteinases. Invest Ophthalmol Vis Sci. 1992;33(12):3325-3331.
6. Cotter CS, Avidano MA, Stringer SP, Schultz GS. Inhibition of proteases in Pseudomonas otitis media in chinchillas. Otolaryngol Head Neck Surg. 1996;115(4):342-351.
7. Lin R, Amizuka N, Sasaki T, et al. 1 Alpha, 25-dihydroxyvitamin D3 promotes vascularization of the chondro-osseous junction by stimulating expression of vascular endothelial growth factor and matrix metalloproteinase-9. J Bone Miner Res. 2002;17(9):1604-1612.
8. Dean DD, Boyan BD, Schwart Z, et al. Effect of 1 alpha, 25-dihydroxyvitamin D3 on metalloproteinase activity and cell maturation in growth plate cartilage in vivo. Endocrine. 2001;14(3):311-323.
9. Tetlow LC, Woolley DE. The effect of 1 alpha, 25-dihydroxyvitamin D3 on matrix metalloproteinase and prostaglandin E2 production by cells of the rheumatoid lesion. Arthritis Res. 1999;1(1):63-70.
10. O-Charoenrat P, Rhys-Evans P,Modjtahedi H, Court W, Box G, Eccles S. Overexpression of epidermal growth factor receptor in human head and neck squamous carcinoma cell lines correlates with matrix metalloproteinase-9 expression and in vitro invasion. Int J Cancer. 2000;86(3):307-317.
11. Yuan GH, Masuko-Hongo K, Sakata M, et al. The role of C-C chemokines and their receptors in osteoarthritis. Arthritis Rheum. 2001;44(5):1056-1070.
12. Moore BA, Aznavoorian S, Engler JA, Windsor LJ. Induction of collagenase-3 (MMP-13) in rheumatoid arthritis synovial fibroblasts. Biochim Biophys Acta. 2000;1502(2):307-318.
13. Stetler-StevensonWG. Dynamics of matrix turnover during pathologic remodeling of the extracellular matrix. Am J Pathol. 1996;148(5):1345-1350.
14. Ishiguro N, Kojima T, Ito T, Iwata H. Matrix metalloproteinase-candidate for clinical joint destruction marker in arthropathy. Connective Tissue. 2001;33(1):43-49.
15. Ohno I, Ohtani H, Nitta Y, et al. Eosinophils as a source of matrix metalloproteinase-9 in asthmatic airway inflammation. Am J Respir Cell Mol Biol. 1997;16(3):212-219.
16. Hoshino M, Nakamura Y, Sim J, Shimojo J, Isogai S. Bronchial subepithelial fibrosis and expression of matrix metalloproteinase-9 in asthmatic airway inflammation. J Allergy Clin Immunol. 1998;102(5):783-788.
17. Kato K, Rokugo M, Terui T, Tagami H. Successful treatment of psoriasis with topical application of active vitamin D3 analogue, 1α, 24-dihydroxycholecalciferol. British J Dermatol. 1986;115:431-433.
18. Ueda K, Suzuki H, Nakagawa S, Kawahara K. Light microscopic and electron microscopic studies on the guinea pig skin and the lesions of psoriasis vulgaris after topical application of 1α, 24-dihydroxycholecalciferol. Acta Dermatol (Kyoto). 1989;84:341-358.
19. Birkedal-Hansen H, Moore WG, Bodden MK, et al. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med. 1993;4(2):197-250.
20. Hayakawa T. Structures and functions of TIMPs. Connective Tissue. 2001;33(1):33-42.